CIM INVESTMENT MANAGEMENT INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$233,436
+31.7%
15,521
+3.6%
0.09%
+22.9%
Q4 2022$177,284
+99.2%
14,9860.0%0.07%
+75.0%
Q3 2022$89,000
+39.1%
14,9860.0%0.04%
+48.1%
Q2 2022$64,000
-55.2%
14,9860.0%0.03%
-43.8%
Q1 2022$143,000
-30.9%
14,986
+141.2%
0.05%
-26.2%
Q3 2021$207,000
-14.1%
6,2140.0%0.06%
-13.3%
Q2 2021$241,0006,2140.08%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders